nai500.com
NAI 500 - SECTORS - Life Science
http://www.nai500.com/sectors/3
Top 100 Mining Executives. Life Science Index: 1135.51 -0.68(. Sort by Change Percent. 214 - 2.25. 025 - 0.28. 690 - 7.25. 3870 - 3.970. 0025 - 0.025. 1485 - 15.32. Replicel Life Sciences Inc. 055 - 0.57. 125 - 1.30. 064 - 0.65. 027 - 0.28. 13201 - 1.3650. 159 - 1.67. AdCare Health Systems Inc. 2200 - 2.340. 282 - 2.97. 11810 - 12.233. 3630 - 3.710. 6420 - 6.620. 154 - 1.60. 6076 - 62.35. 29500 - 3.0300. 3480 - 3.659. 03410 - 0.3600. 286 - 2.90. 143 - 1.50. 650 - 6.77. 376 - 4.46. 250 - 2.53. 420 - 4....
zenithepigenetics.com
Overview - Zenith Epigenetics Ltd.
http://www.zenithepigenetics.com/about/overview.html
Our lead product, a pan selective BET inhibitor, is in clinical development for treatment of solid tumors, including prostate cancer. Effective August 1, 2016, Zenith Epigenetics became a wholly-owned subsidiary of Zenith Capital Corp., a biotechnology investment company and reporting issuer in all Provinces of Canada. In addition to holding all of the shares of Zenith Epigenetics, Zenith Capital holds all of the royalty preferred shares of Resverlogix Corp. 2016 Zenith Epigenetics Ltd. Legal.
zenithepigenetics.com
Overview - Zenith Epigenetics Ltd.
http://www.zenithepigenetics.com/about/overview
Our lead product, a pan selective BET inhibitor, is in clinical development for treatment of solid tumors, including prostate cancer. Effective August 1, 2016, Zenith Epigenetics became a wholly-owned subsidiary of Zenith Capital Corp., a biotechnology investment company and reporting issuer in all Provinces of Canada. In addition to holding all of the shares of Zenith Epigenetics, Zenith Capital holds all of the royalty preferred shares of Resverlogix Corp. 2016 Zenith Epigenetics Ltd. Legal.
gcff.ca
GCFF - GLOBAL CHINESE FINANCIAL FORUM
http://www.gcff.ca/about.html
GCFF - GLOBAL CHINESE FINANCIAL FORUM. Organized by NAI Interactive, the Global Chinese Financial Forum (GCFF) is the most prominent series of bi-lingual financial functions in both North America and China. Established in 2000, GCFF's mandate is to provide a world-class platform connecting both the Asian and North American financial markets. We assemble companies, financial institutions, investors who are interested in exploring new investment ideas and financial opportunities. If any companies would lik...
gcff.cn
GCFF Toronto Conference 2015
http://www.gcff.cn/tor2015.html
地址 7095 Woodbine Ave, Markham, ON L3R 1A3. 7095 Woodbine Avenue Markham Ontario L3R 1A3 Canada. 7095 Woodbine Avenue Markham Ontario L3R 1A3 Canada. 7095 Woodbine Avenue Markham Ontario L3R 1A3 Canada. 7095 Woodbine Avenue Markham Ontario L3R 1A3 Canada. Henry Wong: henry@nai500.com. Sth Brief Information about this section if we have. Tyler Lowes - 公司發展副總裁. Electra Stone Ltd. (TSXV:ELT). Electra Stone Ltd.是一家專門從事玉石和工業礦物勘探和開發的礦業公司,正在卑詩省臨近哈迪港的溫哥華島開采蘋果灣矽酸鋁石場,最近已經開始在卑詩省勘探玉石。 Resverlogix Corp. (TSX: RVX).
pndvhq.com
PNDVHQ | Private Equity Consulting | Pharmaceutical Investment Research | Biotechnology Investment Research | Neutraceutical Investment Research
http://www.pndvhq.com/clients
Pharmaceutical and Bio Tech. Journal Peer Review Invitations. Reviews and Book Chapters. Abstract, Oral and Poster Presentations. Mt Laurel, NJ). Galileo Pharmaceuticals, Inc. Santa Clara, CA). Dana Point, CA). Laguna Niguel, CA). Institutes for Pharmaceutical Discovery. San Franciscso, CA). Calgary, Alberta, Canada). San Francisco, CA). Palo Alto, CA). San Francisco, CA). Web Site Design San Francisco.
bionetwork2015.wbresearch.com
Agenda Day
http://bionetwork2015.wbresearch.com/day-two-change-compliance-to-regulatory-agendaday
October 26 - 28, 2015. The Ritz-Carlton, Laguna Niguel, CA. Contact Us: 1.888.482.6012. One to One Meetings. Download the Latest PDF. Day One: Innovative Dealmaking. Day Two: Change Compliance to Regulatory. Day Three: Connecting Groundbreakers. Become a Media Partner. About our Media Partners. View the Latest Edition of BioNetwork Here. Change Compliance to Regulatory. Day Two: Tuesday, October 27, 2015. Expand All Sessions . Collapse All Sessions [-]. Technology Transfer Officer, Life Sciences. Get to ...
thelifesciencesreport.com
Resverlogix Corp. RVX:TSX
http://www.thelifesciencesreport.com/pub/co/4634
The Life Sciences Report. The Life Sciences Report. Alliance for Regenerative Medicine. Resverlogix Seeks Orphan Status for Lead Drug Candidate (8/3/16). With its lead drug candidate apabetalone already in Phase 3 targeting major adverse cardiac events, Resverlogix has expanded its scope by initiating a Phase 1 study of the small molecule to further investigate its potential applications. John Vandermosten, Zacks Equity Research (7/29/16). John Vandermosten, Zacks Small-Cap Research (6/29/16). Resverlogi...